SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-006386
Filing Date
2022-04-27
Accepted
2022-04-27 16:30:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A fstx_defa14a.htm DEFA14A 31138
2 GRAPHIC img226619892_0.jpg GRAPHIC 746539
3 GRAPHIC img226619892_1.jpg GRAPHIC 409438
  Complete submission text file 0000950170-22-006386.txt   1623864
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37718 | Film No.: 22860112
SIC: 2834 Pharmaceutical Preparations